Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Non-Current Assets (2024 - 2025)

Historic Non-Current Assets for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $1.8 million.

  • Kairos Pharma's Non-Current Assets changed N/A to $1.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2024, which is N/A changed from last year.
  • Per Kairos Pharma's latest filing, its Non-Current Assets stood at $1.8 million for Q2 2025.
  • Over the past 5 years, Kairos Pharma's Non-Current Assets peaked at $1.9 million during Q1 2025, and registered a low of $262000.0 during Q3 2024.